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Abstract 
Agrocybe aegerita (Brig.) Sing is known as a white rot fungus. Antioxidant, antimicrobial 
activity and antiqourum effect on Pseudomonas aeruginosa of A. aegerita methanolic extract 
was investigated. The extract showed good antimicrobial activity. Effects of A. aegerita 
methanolic extract regulated virulence factors in quorum sensing (QS) test, as well as biofilm 
formation on P. aeruginosa and demonstrated reduction of pyocyanin production, twitching 
and swimming motility. Methanolic extract exhibited high antioxidant effect. The studied 
mushroom is a rich source of carbohydrates and proteins. Trehalose was the main free sugar 
while malic acid was the most abundant organic acid. α-, β-, γ- and δ-Tocopherols were also 
found, and oleic acid was the most prevalent fatty acid. A. aegerita can be a good source of 
nutritional and bioactive substances. This research is of great importance due to the 
prevalence of drug-resistant microorganisms and health-beneficial effects of antioxidants. 
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1. Introduction  
An emerging problem associated with misuse of antibiotic therapy is the worldwide 
emergence of higher level tolerance of target organisms against available broad spectrum 
antibiotics.1 As a result, and considering the rapid spread of multidrug resistance, the 
development of new antimicrobial or antipathogenic agents that act upon newly adapted 
microbial targets has become a very pressing priority.2 
Quorum sensing (QS) plays an important role in biofilm formation. It is an intercellular 
signaling system in which bacteria communicate and regulate gene expression by releasing 
small compounds called autoinducers in environment.3 Due to its role in various regulatory 
processes it can serve as an important target. Knowledge about the biofilm formation and 
quorum sensing are resulting in identification of new targets for therapeutics against 
Pseudomonas aeruginosa infection.4  
Despite the huge diversity of compounds with antimicrobial properties, resistance of 
microorganisms to them is increasing dramatically. This fact certainly demands our attention 
and immediate response. Therefore, the search for new sources of compounds with 
antimicrobial properties in natural matrices has been intense in the last years.5,6  
Mushrooms emerged as a good alternative source of new antimicrobials. Some common 
edible mushrooms like Ganoderma lucidum and Lentinus edodes have been studied for that 
purposes,7,8 but isolated substances or crude extracts derived from lesser-known edible 
mushrooms are also interesting. Those species are potential sources of diverse biomolecules 
with nutritional and/or medicinal properties, and could be used for the development of 
medicines, nutraceuticals and food supplements.9,10  
Furthermore, wild mushrooms have also emerged as a source of antioxidant compounds, very 
important to eliminate free radicals and other reactive species produced as a part of the normal 
process of aerobic metabolism, and that can cause structural damage to cells, being implicated 
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in several chronic diseases such as various types of cancer, cardiovascular diseases or 
diabetes.11,12 
It is estimated that there are about 140000 species of mushrooms on earth and of these only 
22000 are known and only a small percentage (5%) has been investigated.6  Therefore, it is 
necessary to expand the knowledge and methods available to identify the bioactive 
components in mushrooms that act on specific target microorganisms or responsible for 
antioxidant properties.  
Edible mushroom Agrocybe aegerita (a synonym of Agrocybe cylindracea; black poplar 
mushroom) is an agaric fungus that colonizes deciduous wood and bark mulch, preferably 
stumps of poplar trees. This mushroom is found in North America, Europe and Asia, and it 
seems to prefer warm or mild climates. It is a popular edible mushroom in southern Europe, 
especially in Italy (so called Pioppino mushroom) where it is also commercially cultured.13  A. 
aegerita is a popular and highly nutritional edible mushroom, which has been used as a 
traditional Chinese herbal medicine. It has an abundant amount of proteins, which accounts 
for 25–30% of dry fruiting bodies.14 
In the present study, a methanolic extract obtained from a wild sample of A. aegerita, 
collected in Serbia, was explored for its antimicrobial activity against plant, animal and 
human pathogens, as well as food spoilage agents, possible inhibition of quorum sensing 
activity on P. aeruginosa, and antioxidant potential. Furthermore, being an edible species, the 
mushroom was fully characterized regarding nutritional properties, hydrophilic and lipophilic 
compounds. 
 
2. Material and methods 
2.1. Standards and reagents 
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Acetonitrile 99.9%, n-hexane 95% and ethyl acetate 99.8% were of HPLC grade from Fisher 
Scientific (Lisbon, Portugal). The fatty acids methyl ester (FAME) reference standard mixture 
37 (standard 47885-U) was purchased from Sigma (St. Louis, MO, USA), as also other 
individual fatty acid isomers and standards of tocopherols, sugars, organic acids and phenolic 
compounds, and trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid). Racemic 
tocol, 50 mg/mL, was purchased from Matreya (PA, USA). 2,2-Diphenyl-1-picrylhydrazyl 
(DPPH) was obtained from Alfa Aesar (Ward Hill, MA, USA). Mueller-Hinton agar (MH) 
and malt agar (MA) were obtained from the Institute of Immunology and Virology, Torlak 
(Belgrade, Serbia). Dimethylsulfoxide (DMSO), (Merck KGaA, Germany) was used as a 
solvent. Methanol and all other chemicals and solvents were of analytical grade and purchased 
from common sources. Water was treated in a Milli-Q water purification system (TGI Pure 
Water Systems, USA).  
 
2.2. Mushroom species 
Agrocybe aegerita was collected from the wood logs of poplar trees at Jabučki rit (Northern 
Serbia) during April 2012 and authenticated by Dr Jasmina Glamočlija (Institute for 
Biological Research "Siniša Stanković"). Voucher specimen has been deposited at the Fungal 
Collection Unit of the Mycological Laboratory, Department of Plant Physiology, Institute for 
Biological Research "Siniša Stanković", Belgrade, Serbia, under number Aa-001-2012. Fresh 
fruiting bodies were randomly divided to smaller samples and immediately dried by 
lyophilization (LH Leybold, Lyovac GT2, Frenkendorf). When reaching constant mass, 
specimens were milled to a fine powder, mixed to obtain an homogenate sample, and kept at 
4ºC untill further analysis. 
 
2.3. Preparation of the extract 
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The methanolic extract was obtained by stirring the dry fruiting body of A. aegerita (8 g) with 
100 mL of methanol for 1 h and subsequently filtered through Whatman No. 4 paper. The 
residue was then re-extracted with 20 mL of methanol for 1 h. The combined methanolic 
extracts were evaporated at 40ºC (rotary evaporator Büchi R-210) to dryness.  The extracts 
were re-dissolved in a) methanol for the antioxidant activity assays (20 mg/mL), b) 5% 
solution of DMSO in distilled water for the antimicrobial activity and antiqourum assays (100 
mg/mL). 
 
2.4. Evaluation of the antimicrobial activity  
2.4.1. Antibacterial activity 
The Gram-positive bacteria Staphylococcus aureus (ATCC 6538), Bacillus cereus (clinical 
isolate), Micrococcus flavus (ATCC 10240) and Listeria monocytogenes (NCTC 7973), and 
the Gram-negative bacteria Pseudomonas aeruginosa (ATCC 27853), Salmonella 
typhimurium (ATCC 13311), Escherichia coli (ATCC 35210), and Enterobacter cloacae 
(human isolate), were used. The antibacterial assay was carried out by a microdilution 
method.15,16 The bacterial suspensions were adjusted with sterile saline to a concentration of 
1.0×105 CFU/mL. Mushroom methanolic extract was dissolved in 5% DMSO solution 
containing 0.1% Tween 80 (v/v) (10 mg/mL) and added in Tryptic Soy broth (TSB) medium 
(100 µL) with bacterial inoculum (1.0×104 CFU per well). The lowest concentrations without 
visible growth (at the binocular microscope) were defined as concentrations that completely 
inhibited bacterial growth (MICs). The MICs obtained from the susceptibility testing of 
various bacteria to tested extracts were determined also by a colorimetric microbial viability 
assay based on reduction of an INT ((p-iodonitrotetrazolium violet) [2-(4-iodophenyl)-3-(4-
nitrphenyl)-5-phenyltetrazolium chloride; Sigma]) color and compared with positive control 
for each bacterial strains. The MBCs were determined by serial sub-cultivation of 2 µL into 
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microtitre plates containing 100 µL of broth per well and further incubation for 24 h. The 
lowest concentration with no visible growth was defined as the MBC, indicating 99.5% 
killing of the original inoculum. The optical density of each well was measured at a 
wavelength of 655 nm by Microplate manager 4.0 (Bio-Rad Laboratories) and compared with 
a blank (broth medium plus diluted extracts) and the positive control. Streptomycin (Sigma P 
7794) and Ampicillin (Panfarma, Belgrade, Serbia) were used as positive controls (1 mg/mL 
in sterile physiological saline). Five percent DMSO was used as a negative control.  
 
2.4.2. Antifungal activity 
Aspergillus fumigatus (human isolate), Aspergillus versicolor (ATCC 11730), Aspergillus 
ochraceus (ATCC 12066), Aspergillus niger (ATCC 6275), Trichoderma viride (IAM 5061), 
Penicillium funiculosum (ATCC 36839), Penicillium ochrochloron (ATCC 9112) and 
Penicillium verrucosum var. cyclopium (food isolate) were used for this test. In order to 
investigate the antifungal activity of mushroom extract, a modified microdilution technique 
was used.17,18 The fungal spores were washed from the surface of agar plates with sterile 
0.85% saline containing 0.1% Tween 80 (v/v) and spore suspension was adjusted with sterile 
saline to a concentration of 1.0×105l. Extract was dissolved in 5% DMSO solution containing 
0.1% Tween 80 (v/v) (10 mg/mL) and added in broth Malt medium with inoculum (0.005-3 
mg/mL for extracts). The lowest concentrations without visible growth (at the binocular 
microscope) were defined as MICs. The fungicidal concentrations (MFCs) were determined 
by serial subcultivation of a 2 µL of tested compounds dissolved in medium and incubated for 
72 h at 28°C. The lowest concentration with no visible growth was defined as MFC indicating 
99.5% killing of the original inoculum. DMSO was used as a negative control, and 
commercial fungicides, bifonazole (Srbolek, Belgrade, Serbia) and ketoconazole 
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(Zorkapharma, Šabac, Serbia), were used as positive controls (1-3000 µg/mL). Five percent 
DMSO was used as a negative control.  
 
2.5. Antiqourum (AQ) sensing activity 
2.5.1. Bacterial strains, growth media and culture conditions 
P. aeruginosa PA01 (ATCC 27853) used in this study is from the lab collection. Bacteria 
were routinely grown in Luria-Bertani (LB) medium (1% w/v NaCl, 1% w/v Tryptone, 0.5% 
w/v yeast extract) with shaking (220 rpm) and cultured at 37 °C. 
 
2.5.2. Biofilm formation 
Biofilm was grown as described previously.19 The effect of different concentrations of extract 
(ranging from 0.5 to 0.125 of MIC) on biofilm forming ability was tested on polystyrene flat-
bottomed microtitre 96 well plates as described by Spoering and Lewis,20 with some 
modifications. Briefly, 100 µL of overnight culture of P. aerugonosa was added to each well 
of the plates in the presence of 100 µL subinhibitory concentrations (subMIC) of extract (0.5, 
0.25 and 0.125 MIC; 0.30 mg/mL, 0.15 mg/mL, 0.07 mg/mL) or 100 mL medium (control). 
After incubation for 24 h at 37º C, each well was washed twice with sterile PBS (pH 7.4), 
dried, stained for 10 min with 0.1 % crystal violet in order to determine the biofilm mass. 
After drying,  200 µL of  95%  ethanol  (v/v)  was  added  to  solubilize  the  dye  that  had  
stained  the  biofilm cells. The excess stain was washed off with dH2O. After  10  min,  the  
content  of  the  wells  was  homogenized  and  the  absorbance at λ= 625 nm was  read on a 
Sunrise™ - Tecan ELISA reader. 
2.5.3. Discs-diffusion method for determination of AQ activity against P. aeruginosa  
Filter paper discs were impregnated with tested extract solutions (subMIC; 0.30 mg/disc, 0.15 
mg/disc, 0.07 mg/disc), streptomycin and ampicillin (subMIC; 0.5 MIC, 0.25 MIC and 0.125 
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MIC; 0.1, 0.05, 0.025 mg/disc for streptomycin and 0.4, 0.2 and 0.1 mg/disc for ampicilin) to 
determine whether they have antiqourum activity against bacteria and impair bacterial growth. 
To do this, filter paper (filter paper 4 mm; Whatman) were used. Discs were soaked in the 
indicated solutions, then dried at room temperature (3 h, protected from light), and aseptically 
placed onto the plates prior to bacterial inoculation. After incubation, it was recorded whether 
the inhibition or antiqourum zones were obtained.21 
 
2.5.4. Twitching and flagella motility 
After growth in the presence or absence of extract, the cells of P. aeruginosa PA01 were 
washed twice with sterile PBS and resuspended in PBS at 1 x 108 cfu/mL (OD of 0.1 at 660 
nm). Briefly, cells were stabbed into a nutrient agar plate with a sterile toothpick and 
incubated overnight at 37° C. Plates were then removed from the incubator and incubated at 
room temperature for two more days. Colony edges and the zone of motility were measured 
with a light microscope.22 Fifty microlitres of tested extract (sub MIC; 0.5 MIC, 0.25 MIC 
and 0.125 MIC) was mixed into 10 mL of molten MH medium and poured immediately over 
the surface of a solidified LBA plate as an overlay. The plate was point inoculated with an 
overnight culture of PAO1 once the overlaid agar had solidified and incubated at 37° C for 3 
days. The extent of swimming was determined by measuring the area of the colony.23 
 
2.5.5. Anti-QS against P. aeruginosa PA01 Pyocyanin  
Overnight culture of P. aeruginosa PA01 was diluted to OD600 nm 0.2. Then, tested extract 
(250 µL disolved as 0.5 MIC, MIC and 2 MIC) was added to P. aeruginosa (4.75 mL) and 
incubated at 37 °C for 24 h. The treated culture was extracted with chloroform (3 mL), 
followed by mixing the chloroform layer with 0.2 M HCl (1 mL). Absorbance of the extracted 
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organic layer was measured using the UV-visible spectrophotometer (UV1601, Shidmazu, 
Kyoto, Japan) at 520 nm.24  
 
2.6. Evaluation of the antioxidant potential  
2.6.1. General 
Successive dilutions were made from the stock solution and submitted to different in vitro 
assays to evaluate the antioxidant activity of the samples.25 The sample concentrations 
providing 50% of antioxidant activity or 0.5 of absorbance (EC50) were calculated from the 
graphs of antioxidant activity percentages (DPPH, β-carotene/linoleate and TBARS assays) or 
absorbance at 690 nm (ferricyanide/Prussian blue assay) against sample concentrations. 
Trolox was used as standard. 
 
2.6.2. Folin-Ciocalteu assay 
The extract solution (1 mL) was mixed with Folin-Ciocalteu reagent (5 mL, previously 
diluted with water 1:10, v/v) and sodium carbonate (75 g/L, 4 mL). The tubes were vortex 
mixed for 15 s and allowed to stand for 30 min at 40°C for colour development. Absorbance 
was then measured at 765 nm (Analytikjena spectrophotometer; Jena, Germany). Gallic acid 
was used to obtain the standard curve and the reduction of Folin-Ciocalteu reagent by the 
samples was expressed as mg of gallic acid equivalents (GAE) per g of extract. 
 
2.6.3. Reducing power or ferricyanide/Prussian blue assay 
The extract solutions with different concentrations (0.5 mL) were mixed with sodium 
phosphate buffer (200 mmol/L, pH 6.6, 0.5 mL) and potassium ferricyanide (1% w/v, 0.5 
mL). The mixture was incubated at 50°C for 20 min, and trichloroacetic acid (10% w/v, 0.5 
mL) was added. The mixture (0.8 mL) was poured in the 48 wells plate, the same with 
 
 
11 
deionised water (0.8 mL) and ferric chloride (0.1% w/v, 0.16 mL), and the absorbance was 
measured at 690 nm in ELX800 Microplate Reader (Bio-Tek Instruments, Inc; Winooski, 
USA). 
 
2.6.4. DPPH radical-scavenging activity assay 
This methodology was performed using the Microplate Reader mentioned above. The reaction 
mixture was made in a 96 wells plate and consisted of 30 µL of a concentration range of the 
extract and 270 µL methanol containing DPPH radicals (6×10-5 mol/L). The mixture was left 
to stand for 30 min in the dark, and the absorption was measured at 515 nm. The radical 
scavenging activity (RSA) was calculated as a percentage of DPPH discolouration using the 
equation: % RSA = [(ADPPH-AS)/ADPPH] × 100, where AS is the absorbance of the solution 
containing the sample and ADPPH is the absorbance of the DPPH solution.  
 
2.6.5. Inhibition of β-carotene bleaching or β-carotene/linoleate assay 
A solution of β-carotene was prepared by dissolving β-carotene (2 mg) in chloroform (10 
mL). Two millilitres of this solution were pipetted into a round-bottom flask. The chloroform 
was removed at 40ºC under vacuum and linoleic acid (40 mg), Tween 80 emulsifier (400 mg), 
and distilled water (100 mL) were added to the flask with vigorous shaking. Aliquots (4.8 mL) 
of this emulsion were transferred into test tubes containing 0.2 mL of a concentration range of 
the extract. The tubes were shaken and incubated at 50ºC in a water bath. As soon as the 
emulsion was added to each tube, the zero time absorbance was measured at 470 nm. β-
Carotene bleaching inhibition was calculated using the following equation: Absorbance after 
2h of assay/initial absorbance) × 100. 
 
2.6.6. Thiobarbituric acid reactive substances (TBARS) assay 
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Porcine (Sus scrofa) brains were obtained from official slaughtering animals, dissected, and 
homogenized with a Polytron in ice cold Tris-HCl buffer (20 mM, pH 7.4) to produce a 1:2 
w/v brain tissue homogenate which was centrifuged at 3000g for10 min. An aliquot (100 µL) 
of the supernatant was incubated with 200 µL samples of a concentration range of the extract 
in the presence of FeSO4 (10 mM; 100 µL) and ascorbic acid (0.1 mM; 100 µL) at 37ºC for 1 
h. The reaction was stopped by the addition of trichloroacetic acid (28% w/v, 500 µL), 
followed by thiobarbituric acid (TBA, 2%, w/v, 380 µL), and the mixture was then heated at 
80ºC for 20 min. After centrifugation at 3000 g for 10 min to remove the precipitated protein, 
the color intensity of the malondialdehyde (MDA)-TBA complex in the supernatant was 
measured by its absorbance at 532 nm. The inhibition ratio (%) was calculated using the 
following formula: Inhibition ratio (%) = [(A - B)/A] × 100%, where A and B were the 
absorbance of the control and the sample solution, respectively. 
 
2.7. Chemical characterization  
2.7.1. Nutritional value 
The samples were analysed for their chemical composition (moisture, proteins, fat, 
carbohydrates and ash) through AOAC procedures.26 The crude protein content (N ×4.38) of 
the samples was estimated by the macro-Kjeldahl method; the crude fat was determined by 
extracting a known weight of powdered sample with petroleum ether, using a Soxhlet 
apparatus; the ash content was determined by incineration at 600±15ºC. Total carbohydrates 
were calculated by difference. The energy contribution was calculated according to the 
following equation: Energy (kcal) = 4 × (g protein + g carbohydrate) + 9 × (g fat).  
 
2.7.2. Sugars 
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Following the extraction procedure described by Reis et al.,25 free sugars were determined by 
a High Performance Liquid Chromatography (HPLC) system consisting of an integrated 
system with a pump (Knauer, Smartline system 1000), degasser system (Smartline manager 
5000) and auto-sampler (AS-2057 Jasco), coupled to a refraction index detector (RIdetector 
Knauer Smartline 2300). Sugars identification was made by comparing the relative retention 
times of sample peaks with standards. Data were analyzed using Clarity 2.4 Software 
(DataApex). Quantification was based on the RI signal response of each standard, using the 
internal standard (IS, raffinose) method and by using calibration curves obtained from the 
commercial standards of each compound. The results were expressed in g per 100 g of dry 
weight. 
 
2.7.3. Organic acids 
Following the extraction procedure described by Barros et al.,27 organic acids were 
determined by ultra fast liquid chromatography (UFLC, Shimadzu 20A series) coupled with a 
photodiode array detector (PDA). The organic acids were quantified by the comparison of the 
area of their peaks recorded at 215 nm with calibration curves obtained from commercial 
standards of each compound. The results were expressed in g per 100 g of dry weight. 
 
2.7.4. Fatty acids 
Following the extraction transesterification procedures described by Reis et al.,25 fatty acids 
were determined using a gas chromatographer (DANI 1000) equipped with a split/splitless 
injector and a flame ionization detector (GC-FID). Fatty acids identification was made by 
comparing the relative retention times of FAME peaks from samples with standards. The 
results were recorded and processed using CSW 1.7 software (DataApex 1.7) and expressed in 
relative percentage of each fatty acid. 
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2.7.5. Tocopherols 
Following the extraction procedure described by Heleno et al.,28 tocopherols were determined 
by HPLC (equipment described above, for sugars composition), and a fluorescence detector 
(FP-2020; Jasco) programmed for excitation at 290 nm and emission at 330 nm. The 
compounds were identified by chromatographic comparison with authentic standards. 
Quantification was based on the fluorescence signal response of each standard, using the IS 
(tocol) method and by using calibration curves obtained from commercial standards of each 
compound. The results were expressed in µg per 100 g of dry weight. 
 
3. Results and Discussion 
 
3.1. Antimicrobial activity 
It was determined that the yield of the methanolic extraction from A. aegerita fruiting body is 
very good, and is 1.40 g out of 5.00 g of fruiting body.  
The methanolic extract of A. aegerita was tested against four species of Gram-negative 
bacteria, four species of Gram-positive bacteria, and eight species of fungi. Extract exhibited 
excellent activity at tested concentrations on all tested microorganisms. Among the tested 
bacteria, S. aureus and P. aeruginosa were the most susceptible to the activity of the extract, 
with MIC (0.59 mg/mL) and MBC (1.18 mg/mL). Commercial antibiotics, streptomycin and 
ampicillin, showed inhibitory activity in the range of 0.05-0.30 mg/mL, and bactericidal 
activity in the range of 0.10-0.50 mg/mL. L. monocytogenes was the most resistant bacteria 
with MIC (4.74 mg/mL) and MBC (9.49 mg/mL) (Table 1). 
Regarding micromycetes, A. versicolor was strongly inhibited by the extract, with MIC value 
of only 0.025 mg/mL, and MBC 0.95 mg/mL. The most resistant microfungi was A. fumigatus 
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with inhibitory concentration at 2.38 mg/mL and fungicidal concentration 18.96 mg/mL 
(Table 1). Antifungal drugs ketoconazole and bifonazole exhibited high activity in the range 
of 0.10-3.50 mg/mL (Table 1). It is important to notice that the extract showed inhibitory 
activity against all the tested bacteria and micromycetes.  
Numerous mushroom extracts have been reported to have antimicrobial activity against 
pathogenic microorganisms, including extracts from Agaricus bisporus (the most cultivated 
mushroom in the world), Armillaria mellea, Boletus edulis, Cantharellus cibarius, just to 
mention a few.9 It should be highlighted that as far as our literature survey could ascertain, 
scarce information is available on the in vitro antimicrobial activity of A. aegerita extracts. 
There are literature data (from 1992) concerning the antifungal activity of the extract from the 
submerged culture, and since then methodology has significantly changed concerning the 
isolation of the extracts and assays for antimicrobial activity evaluation.29 Also, data 
concerning the compound agrocybolacton, derived from the culture representatives of the 
genus Agrocybe, showed moderate antibacterial activity against Gram-positive bacteria B. 
subtilis and M. smegmatis.30 Agrocybin, a peptide isolated from A. dura and A. cylindracea 
exhibited activity against Gram-negative bacteria31 and also antifungal activity.32 Since there 
are no literature data providing information about antimicrobial activity of crude extracts of A. 
aegerita, these results are of great importance.  
 
3.2. Biofilm formation 
The effect of A. aegerita extract on biofilm formation of P. aeruginosa was tested with 0.5, 
0.25 and 0.125 of determined MIC. Table 2 shows that the extract tested reduced biofilm 
formation better than streptomycin and ampicillin, especially at 0.5 MIC. The extract reduced 
biofilm formation in 84.24%, while streptomycin and ampicillin reduced biofilm in 50.60% 
and 30.84%, respectively. 
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The quorum-sensing inhibition zones were determined by disc diffusion method. It can be 
seen that extract showed antiquorum sensing (AQ) activity at all concentrations in range of 
7.70-10.30 mm. Ampicillin possessed AQ activity at higher concentration (7.60 mm), while 
streptomycin showed the best AQ activity presenting the zones in range of 15.50-22.06 mm 
(Table 2). 
The flask incubation assay was used to quantify quorum sensing inhibitory activity of the 
extract that produced quorum-sensing inhibition zones. The tested extract of A. aegerita 
demonstrated concentration-dependent pyocyanin inhibitory activity and showed reduction of 
pigment in all tested concentration, sub MIC, MIC and 2 MIC. The best reduction pyocyainin 
ability was noticed at 2 MIC. In general, all the tested concentrations (sub MIC, MIC and 2 
MIC) showed higher reduction ability of pigment. A decrease level in green pigment content 
was demonstrated in the extract at all the tested concentrations. The extract showed higher 
reduction of pigment than ampicillin and streptomycin (Figure 1). Promising anti-quorum 
sensing compounds have been demonstrated to disrupt bacterial biofilms and make the 
bacteria more susceptible to antibiotics, and these compounds also provide the ability to 
reduce bacterial virulence factors as well as promote clearance of bacteria in infectious animal 
models. Many mechanisms of actions have been proposed to interfere with the quorum 
sensing system such as inhibition of biosynthesis of autoinducer molecules, inactivation or 
degradation of the autoinducer, interference with the signal receptor, and inhibition of the 
genetic regulation system.33 
In addition to QS, the initiation of biofilm formation by P. aeruginosa depends on two cell-
associated structures; the flagellum and type IV pili.22,34 The flagellum is responsible for 
swimming motility while the type IV pili are responsible for twitching motility.35 Both types 
of motility are important in the initial stages of biofilm formation by P. aeruginosa.22,34 
Therefore, we tried to determine if our extract influence on either one or both motilities. On 
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swimming plates, the motile strain PAO1 was used as the 100% standard (control) for motility 
while the Petri dishes with the same strain plus A. aegerita extract were compared with 
control. Extract reduced the twitching motility of P. aeruginosa. The normal colonies of P. 
aeruginosa, i.e. in the absence of the extract, were flat with a rough appearance displaying 
irregular colony edges (Fig. 2B) and a hazy zone surrounding the colony. The cells were in a 
very thin layer. After 2 days of incubation at ambient temperature, colony expansion occurred 
very rapidly due to twitching motility, the control P. aeruginosa isolates produced swimming 
zones to 100% (Table 2) and it was 14.0 mm. Bacteria that were grown with the A. aegerita 
extract solution were incapable of producing such a twitching zone and had almost round, 
smooth, regular colony edges, the flagella were reduced both in size and in numbers, and the 
colony diameter swimming zones was also reduced (15.33 mm) (Fig. 2A, Table 2). 
Streptomycin reduced the flagellas completely (Fig. 2C), while Ampicillin did not affect the 
formation of flagella at all (Fig. 2D). 
In summary, our study indicated that A. aegerita extract possessed antimicrobial, antibiofilm 
and anti-quorum sensing activity. Inhibition of bacterial quorum sensing offers new strategy 
for the treatment of bacterial infections. Anti-quorum sensing property of this plant species 
may play an important role in antibacterial activity and offers an additional strategy for 
fighting bacterial infection. 
 
3.3. Aantioxidant activity 
Antioxidant activity of the methanolic extract was measured by four different methods (Table 
3). These assays measured free radical scavenging activity, reducing power and lipid 
peroxidation inhibition. The extract gave 17.36 mg GAE/g extract in the Folin-Ciocalteu 
assay, and revealed high DPPH radical-scavenging activity assay (EC50= 7.23 mg/mL). 
Slightly higher effect was observed in the β-carotene/linoleate assay (EC50 = 6.11 mg/mL), 
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while Ferricyanide/Prussian blue assay and TBARS assays showed even higher effects (EC50 
= 2.66 mg/ml; EC50 = 0.39 mg/mL, respectively). The same behavior was previously reported 
for other mushroom species.36 The observed antioxidant activity may be the consequence of 
the presence of different antioxidant compounds described in the chemistry section, mainly 
phenolic acids. Lo and Cheung13 reported antioxidant activity of the methanol crude extract of 
A. aegerita and its fractions, isolated by liquid–liquid partition, using scavenging activity of 
2,20-azinobis-(3-ethylbenzthiazoline-6-sulphonic acid) radical cation (ABTS) and inhibition 
of lipid peroxidation of rat brain homogenate. The ethyl acetate (EA) fraction, which showed 
the most potent antioxidant activity in the mentioned two assays, was further fractionated by a 
Sephadex LH-20 column into four subfractions (EA1–EA4). EA3 exhibited the strongest 
radical-scavenging activity in the ABTS and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical, 
and showed a similar extent of in vitro inhibition of human LDL oxidation to caffeic acid. 
Significant correlation was found between the total phenolic content and the antioxidant 
activity (p < 0:01) in the EA fraction and its subfractions.  
 
3.4. Chemical composition 
Results regarding the nutritional value of A. aegerita are presented in Table 4. Carbohydrates 
and proteins are the most abundant compounds (84.51 g/100 g dw and 6.68 g/100 g dw, 
respectively). Mushrooms are generally considered to be a good source of digestable proteins, 
and are reported to contain all the essential amino acids needed in the human diet.37 Ash 
content is low (6.69 g/100 g dw); A. aegerita is also poor in fat (2.13 g/100 g dw) and 
energetic value (383.91 kcal/100 g dw), which makes this mushroom a good candidate for 
low-caloric diets (Table 4). Trehalose was the dominant sugar (12.49 g/100g dw), while 
mannitol was presented at 0.93 g/100g dw (Table 4). This is in concordance with previous 
reports on mushroom sugars composition that also mentioned these molecules as the most 
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predominant.38 Malic acid was the most abundant organic acid (1.82 g/100 g dw), followed by 
citric acid (0.88 g/100 g), then fumaric acid (0.26 g/100 g) and oxalic acid (0.09 g/100 g) 
(Table 4).  
A. aegerita polyunsaturated fatty acids- PUFA (78.60%) levels were higher than saturated and 
monounsaturated fatty acids (17.93% and 3.47%, respectively) (Table 5). As already 
mentioned, mushrooms are known for their low fat content, but also for predominance in 
PUFA over SFA.39 The main fatty acids found by Shuai et al.40 in A. aegerita were linoleic 
acid (C18:2n6c) > palmitic acid (C16:0) > oleic acid (18:1n9c). A total FA value of 33.13 
mg/10 g was reported in literature for A. aegerita, while ratio between unsaturated fatty acids 
and saturated fatty acids was 3.80.  
Tocopherols were also determined, since these compounds have the important ability to 
scavenge free radicals, and are considered to protect our organisms against degenerative 
diseases. For a long time, α-tocopherol was considered to be the most active form of vitamin 
E and was reported to have the highest biological activity. However, recent studies have 
shown that the other forms are also active.29 For the studied mushroom, γ-tocopherol was the 
most abundant isoform (86.08 µg/100 g dw), followed by β-tocopherol (8.80 µg/100 g dw), δ-
tocopherol (3.40 µg/100 g dw) and α-tocopherol (2.10 µg/100 g dw; Table 5). Our literature 
survey showed that there are only few avalialble studies concerning A. aegerita chemical 
composition. Diyabalanage et al.,41 described the presence of ceramide, methyl- β-D-
glucopyranoside and α-D-glucopyranoside, along with linoleic acid and its methyl ester. Our 
studies are in accordance with previous studies reporting the presence of palmitic acid, 
linoleic acid, mannitol and trehalose in the fruiting body of A. aegerita.41 A novel lectin was 
isolated from water extract A. aegerita from China by affinity chromatography.42 A. aegerita 
was also reported to contain several bioactive metabolites, such as indole derivatives with free 
radical-scavenging ability,42 polysaccharides with hypoglycemic activity43 and agrocybin, a 
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peptide with anti-fungal activity.32 Previously, Gao et al.,44 reported that the protein 
components from A. aegerita showed tumor rejection activity. Also two antitumor lectins, 
AAL and AAL-2, were identified from the protein components of A. aegerita.45,46  
Nowadays, mushroom research is intense and hundreds of species have demonstrated a broad 
spectrum of activities, including antimicrobial and antioxidant.47 It is evident that there are 
very good effects of extracts, but there is a gap in the identification of the individual 
compounds responsible for antimicrobial properties. Only a few low-molecular weight 
compounds and some peptides and proteins have been described. After elucidation of the 
mechanism of mushroom extracts activity or pure compounds activity, mushroom metabolites 
or other related compounds could be used to develop nutraceuticals or microorganisms 
effective drugs. 
The reason that some of the mushroom extracts/preparations are not available yet as 
medicines may be the difficulty relating to massive production. Since A. aegerita is part of the 
mushroom cultivation, and the fungal material is primarily available, in the light of new data 
of the antimicrobial activity and mechanisms of action concerning antiqourum activity of the 
extract, attention should definitely be dedicated to it. 
 
4. Conclusion 
Our results concerning chemical profile and bioactive characteristics of A. aegerita extract 
and gaining knowledge about the mechanisms of action of the different mushroom 
compounds might lead to the usage of new active principles from this mushroom as a source 
of functional food. 
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Table 1. Antibacterial and antifungal activities of Agrocybe aegerita methanolic extract 
(mg/mL) (mean ± SD). 
 
 
 Bacteria S. aureus B. cereus L.monocytogenes M.flavus P.aeruginosa E.coli S.typhimurium En. cloacae 
A. aegerita 
 
MIC 
MBC 
0.59±0.01 1.18±0.01 4.74±0.01 2.38±0.02 0.59±0.02 2.38±0.02 2.38±0.01 1.18±0.03 
1.18±0.02 2.38±0.03 9.49±0.03 4.74±0.03 1.18±0.03 4.74±0.03 4.74±0.01 2.38±0.01 
Streptomycin 
 
MIC 
MBC 
0.25±0.03 0.05±0.02 0.15±0.03 0.125±0.02 0.05±0.03 0.05±0.01 0.05±0.02 0.05±0.03 
0.5±0.01 0.10±0.03 0.30±0.01 0.25±0.01 0.10±0.03 0.10±0.01 0.10±0.02 0.10±0.02 
Ampicillin 
 
MIC 
MBC 
0.10±0.03 0.10±0.01 0.15±0.03 0.10±0.03 0.10±0.01 0.30±0.02 0.15±0.01 0.15±0.01 
0.15±0.01 0.15±0.02 0.30±0.03 0.15±0.02 0.20±0.03 0.50±0.03 0.20±0.03 0.20±0.01 
 Fungi A.fumigatus A.versicolor A.ochraceus A.niger T.viride P.funiculosum P.ochrochloron P.cyclopium 
A. aegerita 
 
MIC 
MFC 
2.38±0.01 0.025±0.01 1.19±0.01 2.38±0.02 2.38±0.02 2.38±0.02 1.19±0.01 2.38±0.00 
18.96±0.02 0.95±0.03 4.74±0.03 9.49±0.03 2.38±0.03 4.74±0.03 4.74±0.01 4.47±0.01 
Ketoconazole 
 
MIC 
MFC 
0.20±0.03 0.20±0.02 0.15±0.03 0.20±0.02 0.20±0.03 2.50±0.01 0.20±0.02 0.25±0.03 
0.50±0.01 0.50±0.03 0.20±0.01 0.50±0.01 0.30±0.03 3.50±0.01 0.50±0.02 0.50±0.02 
Bifonazole 
 
MIC 
MFC 
0.15±0.03 0.10±0.01 0.15±0.03 0.15±0.03 0.10±0.01 0.20±0.02 0.20±0.01 0.25±0.00 
0.20±0.01 0.20±0.02 0.20±0.03 0.20±0.02 0.20±0.03 0.25±0.03 0.25±0.03 0.50±0.03 
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Table 2. Effects of Agrocybe aegerita methanolic extract on biofilm formation of P. 
aeruginosa (PAO1), disc-diffusion method for detection of antiquorum (AQ) concentrations 
and twitching activity. 
 
Twitching  activity    
Agents Colony diameter (mm ± SD) Colony color Colony edge 
A. aegerita 15.33±4.51 green with white edges reduced flagella 
Streptomycin 5.00±0.06 white flat  
Ampicillin 12.00±1.00 white regular flagella 
Control P.a. 109 14.00±1.00 green regular flagella 
*Biofilm formation values were calculated as: (mean A620 treated well)/(mean A620 control well)x100.  
Values are expressed as means ± SD. In each column, different letters mean significant differences between samples (p<0.05). 
** - No effect of AQ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biofilm formation* (%) AQ** (mm) 
Agents 0.5MIC 0.25MIC 0.125MIC 0.125 MIC 0.25 MIC 0.5 MIC 
A. aegerita 15.76±0.03 44.97±0.30 80.63±0.46 7.70±0.58 8.00±0.00 10.30±0.58 
Ampicillin  69.16±0.65 56.46±0.46 92.16±0.37 - - 7.6±0.6 
Streptomycin  49.40±0.46 70.97±0.36 88.36±0.42 - 15.0±2.1 22.6±2.3 
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Table 3. Antioxidant properties of the studied edible mushroom (mean ± SD). 
 
In each row different letters mean significant differences between species (p<0.05). Concerning the Folin-Ciocalteu assay, higher values 
mean higher reducing power; for the other assays, the results are presented in EC50 values, what means that higher values correspond to lower 
reducing power or antioxidant potential. EC50: Extract concentration corresponding to 50% of antioxidant activity or 0.5 of absorbance for 
the Ferricyanide/Prussian blue assay. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Reducing power Scavenging activity Lipid peroxidation inhibition 
Species 
Folin-Ciocalteu 
(mgGAE/g extract) 
Ferricyanide/Prussian 
blue (EC50;mg/ml) 
DPPH radical-
scavenging activity 
(EC50; mg/ml) 
β-
carotene/linoleate 
(EC50; mg/ml) 
TBARS  
(EC50; mg/ml) 
A. 
aegerita 
17.36 ± 0.88 2.66 ± 0.10 7.23 ± 0.18 6.11 ± 1.60 0.39 ± 0.06 
 
 
31 
Table 4. Nutritional value and hydrophilic compounds of Agrocybe aegerita (mean ± SD). 
 
Ash 
(g/100 g dw) 
Proteins 
(g/100 g dw) 
Fat 
(g/100 g dw) 
Carbohydrates 
(g/100 g dw) 
Energy 
(kcal/100 g dw) 
6.69 ± 0.33 6.68 ± 0.26 2.13 ± 0.02 84.51 ± 0.24 383.91 ± 1.02 
Mannitol 
(g/100 g dw) 
Trehalose 
(g/100 g dw) 
Total 
(g/100 g dw) 
  
0.93 ± 0.01 12.49 ± 0.09 13.42 ± 0.08   
Oxalic acid 
(g/100 g dw) 
Malic Acid 
(g/100 g dw) 
Citric Acid 
(g/100 g dw) 
Fumaric Acid 
(g/100 g dw) 
Total 
(g/100 g dw) 
0.09 ± 0.01 1.82 ± 2.21 0.88 ± 0.01 0.26±0.01 3.06±2.23 
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Table 5. Lipophilic compounds of Agrocybe aegerita (mean ± SD). 
 
C6:0 0.10 ± 0.01 
C8:0 0.13 ± 0.01 
C10:0 0.08 ± 0.00 
C12:0 0.06 ± 0.00 
C14:0 0.23 ± 0.00 
C14:1 0.01 ± 0.00 
C15:0 0.43 ± 0.00 
C16:0 13.07 ± 0.11 
C16:1 0.29 ± 0.00 
C17:0 0.25 ± 0.00 
C18:0 2.13 ± 0.02 
C18:1n9 3.03 ± 0.00 
C18:2n6 78.40 ± 0.10 
C18:3n3 0.07 ± 0.00 
C20:0 0.49 ± 0.00 
C20:1 0.05 ± 0.00 
C20:2 0.03 ± 0.00 
C20:3n3+C21:0 0.08 ± 0.00 
C20:5n3 0.02 ± 0.00 
C22:0 0.40 ± 0.01 
C22:1n9 0.02 ± 0.01 
C23:0 0.11 ± 0.01 
C24:0 0.45 ± 0.01 
C24:1 0.07 ± 0.02 
Total SFA (% of total FA) 17.93 ± 0.07 
Total MUFA (% of total FA) 3.47 ± 0.03 
Total PUFA (% of total FA) 78.60 ± 0.10 
α-Tocopherol 2.10 ± 1.10 
β-Tocopherol 8.80 ± 2.20 
γ-Tocopherol 86.08 ± 12.90 
δ-Tocopherol 3.40 ± 0.20 
Total (µg/100 g dw) 100.38 ± 13.81 
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Figure 1. Reduction of pyocyanin pigment by Agrocybe aegerita extract.
 
 
34 
 
Figure 2. Light microscopy of colony edges of P. aeruginosa in twitching motility plates, 
grown in the presence or absence of A. aegerita extract. 
The colonies from the bacteria grown with A. aegerita extract (A) were with small changes in flagella shape and 
numbers. P. aeruginosa produced a flat, widely spread, irregularly shaped colony in the absence of extracts (B). 
P. aeruginosa colony with presence of Streptomycin without flagella (C) and Ampicillin with almost regularly 
formed flagella (D). Magnification: (A-D) x100. 
 
 
 
 
 
